Invega Trinza (paliperidone palmitate) for the Treatment for Schizophrenia

Invega Trinza (paliperidone palmitate), an atypical antipsychotic, is a three-month injection that is the first, and only, four-times-a-year drug indicated to treat schizophrenia .
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news